proqolid

Home > Instruments > Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)

Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD)

 

Author(s)

 

Purpose

  • Pathology:

Congenital, hereditary, and neonatal diseases and abnormalities

Immune system diseases

Skin and connective tissue diseases

  • Disease:

Dermatitis, Atopic

  • Objective:

To assess the quality of life of parents of children (under 8) with atopic dermatitis

  • Population for intended use:

Caregivers

 
 

Characteristics

  • Type of instrument:

Health-Related Quality of Life - HRQL (incl. health status)

  • Administration mode:

Self-administered

  • Number of items:

28

  • Recall/Observation period:

At the moment

 
 

Language(s)

  • Original language:

English for the UK

  • List of existing translations:

The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.

PIQoL-AD

Dutch for the Netherlands
English for the USA
French for France
German for Germany
Hungarian
Italian for Italy
Spanish for Spain
 

Bibliographic reference(s) of the original questionnaire

Whalley D, Huels J, McKenna SP, Van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis. Pediatrics. 2002 Dec;110(6):1133-6


McKenna SP, Doward LC, Niero M, Erdman R. Development of needs-based quality of life instruments. Value Health. 2004 Sep-Oct;7 Suppl 1:S17-21


McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, Baro E, Cook SA, Crickx B, Frech F, van Assche D. International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res. 2005 Feb;14(1):231-41


McKenna SP, Whalley D, de Prost Y, Staab D, Huels J, Paul CF, van Assche D. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life. J Eur Acad Dermatol Venereol. 2006 Mar;20(3):248-54

Last update: July 2007

Last update in collaboration with the author: June 2007